BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28985353)

  • 1. Loss of ADAMTS3 activity causes Hennekam lymphangiectasia-lymphedema syndrome 3.
    Brouillard P; Dupont L; Helaers R; Coulie R; Tiller GE; Peeden J; Colige A; Vikkula M
    Hum Mol Genet; 2017 Nov; 26(21):4095-4104. PubMed ID: 28985353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An additional case of Hennekam lymphangiectasia-lymphedema syndrome caused by loss-of-function mutation in ADAMTS3.
    Scheuerle AE; Sweed NT; Timmons CF; Smith ED; Alcaraz WA; Shinde DN
    Am J Med Genet A; 2018 Dec; 176(12):2858-2861. PubMed ID: 30450763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain.
    Roukens MG; Peterson-Maduro J; Padberg Y; Jeltsch M; Leppänen VM; Bos FL; Alitalo K; Schulte-Merker S; Schulte D
    Circ Res; 2015 May; 116(10):1660-9. PubMed ID: 25814692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic mutation of FBXL7 suggests a novel form of Hennekam syndrome.
    Boone PM; Paterson S; Mohajeri K; Zhu W; Genetti CA; Tai DJC; Nori N; Agrawal PB; Bacino CA; Bi W; Talkowski ME; Hogan BM; Rodan LH
    Am J Med Genet A; 2020 Jan; 182(1):189-194. PubMed ID: 31633297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
    Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
    J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
    Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
    Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multiplex Kindred with Hennekam Syndrome due to Homozygosity for a CCBE1 Mutation that does not Prevent Protein Expression.
    Jackson CC; Best L; Lorenzo L; Casanova JL; Wacker J; Bertz S; Agaimy A; Harrer T
    J Clin Immunol; 2016 Jan; 36(1):19-27. PubMed ID: 26686525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the genotypic spectrum of CCBE1 mutations in Hennekam syndrome.
    Crawford J; Bower NI; Hogan BM; Taft RJ; Gabbett MT; McGaughran J; Simons C
    Am J Med Genet A; 2016 Oct; 170(10):2694-7. PubMed ID: 27345729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome.
    Alders M; Al-Gazali L; Cordeiro I; Dallapiccola B; Garavelli L; Tuysuz B; Salehi F; Haagmans MA; Mook OR; Majoie CB; Mannens MM; Hennekam RC
    Hum Genet; 2014 Sep; 133(9):1161-7. PubMed ID: 24913602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.
    Jeltsch M; Jha SK; Tvorogov D; Anisimov A; Leppänen VM; Holopainen T; Kivelä R; Ortega S; Kärpanen T; Alitalo K
    Circulation; 2014 May; 129(19):1962-71. PubMed ID: 24552833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel CCBE1 mutation leading to a mild form of hennekam syndrome: case report and review of the literature.
    Frosk P; Chodirker B; Simard L; El-Matary W; Hanlon-Dearman A; Schwartzentruber J; Majewski J; ; Rockman-Greenberg C
    BMC Med Genet; 2015 Apr; 16():28. PubMed ID: 25925991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the Most Deleterious Missense Nonsynonymous Single-Nucleotide Polymorphisms of Hennekam Syndrome-Causing CCBE1 Gene, In Silico Analysis.
    Shinwari K; Guojun L; Deryabina SS; Bolkov MA; Tuzankina IA; Chereshnev VA
    ScientificWorldJournal; 2021; 2021():6642626. PubMed ID: 34234628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis.
    Le Guen L; Karpanen T; Schulte D; Harris NC; Koltowska K; Roukens G; Bower NI; van Impel A; Stacker SA; Achen MG; Schulte-Merker S; Hogan BM
    Development; 2014 Mar; 141(6):1239-49. PubMed ID: 24523457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific fibroblast subpopulations and neuronal structures provide local sources of Vegfc-processing components during zebrafish lymphangiogenesis.
    Wang G; Muhl L; Padberg Y; Dupont L; Peterson-Maduro J; Stehling M; le Noble F; Colige A; Betsholtz C; Schulte-Merker S; van Impel A
    Nat Commun; 2020 Jun; 11(1):2724. PubMed ID: 32483144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.
    Gordon K; Schulte D; Brice G; Simpson MA; Roukens MG; van Impel A; Connell F; Kalidas K; Jeffery S; Mortimer PS; Mansour S; Schulte-Merker S; Ostergaard P
    Circ Res; 2013 Mar; 112(6):956-60. PubMed ID: 23410910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of Potential Immunodeficiency Unveils Hennekam Lymphangiectasia-Lymphedema Syndrome.
    Kaut S; Bucciol G; Moens L; Meyts I
    J Clin Immunol; 2021 Oct; 41(7):1674-1676. PubMed ID: 34176065
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow.
    Betterman KL; Sutton DL; Secker GA; Kazenwadel J; Oszmiana A; Lim L; Miura N; Sorokin L; Hogan BM; Kahn ML; McNeill H; Harvey NL
    J Clin Invest; 2020 Jun; 130(6):3315-3328. PubMed ID: 32182215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAMTS2 and ADAMTS14 can substitute for ADAMTS3 in adults for pro-VEGFC activation and lymphatic homeostasis.
    Dupont L; Joannes L; Morfoisse F; Blacher S; Monseur C; Deroanne CF; Noël A; Colige AC
    JCI Insight; 2022 Apr; 7(8):. PubMed ID: 35316211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of the phenotype in Hennekam syndrome: a case with new manifestations.
    Angle B; Hersh JH
    Am J Med Genet; 1997 Aug; 71(2):211-4. PubMed ID: 9217224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hennekam syndrome: a case report and review of literature].
    Zhang N; Shen WB; Cai HC; Yan XM; Liu SL; Wu D; Sun G; Qian JM; Dun ZN; Zhao YQ
    Zhonghua Nei Ke Za Zhi; 2013 Mar; 52(3):192-6. PubMed ID: 23856108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.